1. Home
  2. APGE vs CUBI Comparison

APGE vs CUBI Comparison

Compare APGE & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • CUBI
  • Stock Information
  • Founded
  • APGE 2022
  • CUBI 1994
  • Country
  • APGE United States
  • CUBI United States
  • Employees
  • APGE N/A
  • CUBI N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • CUBI Major Banks
  • Sector
  • APGE Health Care
  • CUBI Finance
  • Exchange
  • APGE Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • APGE 2.4B
  • CUBI 2.2B
  • IPO Year
  • APGE 2023
  • CUBI 2012
  • Fundamental
  • Price
  • APGE $52.11
  • CUBI $65.27
  • Analyst Decision
  • APGE Strong Buy
  • CUBI Strong Buy
  • Analyst Count
  • APGE 7
  • CUBI 8
  • Target Price
  • APGE $93.14
  • CUBI $74.50
  • AVG Volume (30 Days)
  • APGE 680.5K
  • CUBI 303.6K
  • Earning Date
  • APGE 11-11-2025
  • CUBI 10-30-2025
  • Dividend Yield
  • APGE N/A
  • CUBI N/A
  • EPS Growth
  • APGE N/A
  • CUBI N/A
  • EPS
  • APGE N/A
  • CUBI 4.05
  • Revenue
  • APGE N/A
  • CUBI $596,459,000.00
  • Revenue This Year
  • APGE N/A
  • CUBI $16.37
  • Revenue Next Year
  • APGE N/A
  • CUBI $6.49
  • P/E Ratio
  • APGE N/A
  • CUBI $16.07
  • Revenue Growth
  • APGE N/A
  • CUBI N/A
  • 52 Week Low
  • APGE $26.20
  • CUBI $40.75
  • 52 Week High
  • APGE $63.50
  • CUBI $72.51
  • Technical
  • Relative Strength Index (RSI)
  • APGE 84.17
  • CUBI 45.14
  • Support Level
  • APGE $39.21
  • CUBI $63.76
  • Resistance Level
  • APGE $40.48
  • CUBI $66.99
  • Average True Range (ATR)
  • APGE 2.26
  • CUBI 1.61
  • MACD
  • APGE 1.18
  • CUBI -0.18
  • Stochastic Oscillator
  • APGE 92.22
  • CUBI 28.18

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: